Etrolizumab Population Pharmacokinetics (Pop PK) and Covariate Analysis in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

被引：0
|
作者：
Wei, Xiaohui [1 ]
Luca, Diana [1 ]
Wang, Yehong [1 ]
O'Byrne, Sharon [1 ]
Erickson, Rich [1 ]
Davis, John [1 ]
Tang, Meina [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2014年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1673
引用
收藏
页码：S496 / S496
页数：1
相关论文
共 50 条
  • [21] Bowel Urgency and Abdominal Pain in Patients With Moderately to Severely Active Ulcerative Colitis in the Etrasimod ELEVATE UC Clinical Program: A Post Hoc Analysis
    Dubinsky, Marla C.
    Chaparro, Maria
    Armuzzi, Alessandro
    Irving, Peter M.
    Allez, Matthieu
    Panaccione, Remo
    Goetsch, Martina
    Bartolome, Lauren
    Bananis, Eustratios
    Wu, Joseph
    Wosik, Karolina
    Bhattacharjee, Abhishek
    Smith, Christina C.
    Sands, Bruce E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S889 - S890
  • [22] Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis
    Yasuo Suzuki
    Satoshi Motoya
    Hiroyuki Hanai
    Takayuki Matsumoto
    Toshifumi Hibi
    Anne M. Robinson
    Nael M. Mostafa
    Jingdong Chao
    Vipin Arora
    Anne Camez
    Roopal B. Thakkar
    Mamoru Watanabe
    Journal of Gastroenterology, 2014, 49 : 283 - 294
  • [23] Integrated summary of safety of obefazimod for patients with moderately to severely active ulcerative colitis
    Vermeire, S.
    Peyrin-Biroulet, L.
    Danese, S.
    Dubinsky, M.
    Dulai, P. S.
    Tilg, H.
    Siegmund, B.
    Hisamatsu, T.
    Shan, K.
    Jacobstein, D.
    Cataldi, F.
    Rabbat, C.
    Sands, B. E.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1554 - i1555
  • [24] Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis
    Suzuki, Yasuo
    Motoya, Satoshi
    Hanai, Hiroyuki
    Matsumoto, Takayuki
    Hibi, Toshifumi
    Robinson, Anne M.
    Mostafa, Nael M.
    Chao, Jingdong
    Arora, Vipin
    Camez, Anne
    Thakkar, Roopal B.
    Watanabe, Mamoru
    JOURNAL OF GASTROENTEROLOGY, 2014, 49 (02) : 283 - 294
  • [25] Comparative efficacy of biologics in the treatment of moderately to severely active ulcerative colitis (UC): A systematic review and network meta-analysis
    Vickers, A. D.
    Mody, R. R.
    Bergman, A.
    Ling, C. S.
    Ainsworth, C.
    Medjedovic, J.
    Smyth, M.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S357 - S358
  • [26] Comparative Efficacy of Biologics in the Treatment of Moderately to Severely Active Ulcerative Colitis (UC): A Systematic Review and Network Meta-Analysis
    Vickers, Adrian D.
    Mody, Reema
    Bergman, Annika
    Ling, Caroline S.
    Ainsworth, Claire
    Medjedovic, Jasmina
    Smyth, Michael D.
    GASTROENTEROLOGY, 2015, 148 (04) : S272 - S272
  • [27] Pharmacology of Etrolizumab in a Phase 2 Study in Moderate-to-Severely Active Ulcerative Colitis
    Looney, Caroline
    Fuh, Franklin
    Tang, Meina T.
    Wei, Xiaohui
    Keir, Mary E.
    Tew, Gaik W.
    Eastham-Anderson, Jeffrey
    Diehl, Lauri
    Salas, Azucena
    De Hertogh, Gert
    Francom, Steven
    Gilbert, Houston
    Luca, Diana
    Egen, Jackson G.
    Vermeire, Severine
    Mansfield, John C.
    Lamb, Christopher A.
    Feagan, Brian G.
    Panes, Julian
    Baumgart, Daniel C.
    Schreiber, Stefan
    Dotan, Iris
    Sandborn, William
    Rutgeerts, Paul J.
    Lu, Timothy
    O'Byrne, Sharon
    Williams, Marna
    GASTROENTEROLOGY, 2014, 146 (05) : S240 - S240
  • [28] Long-term Safety of Ozanimod in Patients with Moderately to Severely Active Ulcerative Colitis (UC) and Relapsing Multiple Sclerosis (RMS) Studies
    Rubin, David T.
    Wolf, Douglas C.
    Alekseeva, Olga
    Charles, Lorna
    Afsari, Sonia
    Petersen, Ann Katrin
    Sheffield, James
    Li, Hongjuan
    Silva, Diego
    Lublin, Fred D.
    Cree, Bruce
    Cohen, Jeffrey
    Danese, Silvio
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S396 - S396
  • [29] The ACT trials: Incremental benefit of second and third induction doses of infliximab in patients with moderately-to-severely active ulcerative colitis (UC)
    Sandborn, William J.
    Rutgeerts, Paul J.
    Feagan, Brian
    Reinisch, Walter
    Olson, Allan
    Johanns, Jewel R.
    Lang, Yinghua
    Rachmilewitz, Daniel
    Hanauer, Stephen B.
    Lichtenstein, Gary R.
    de Villiers, Willem J.
    Present, Daniel H.
    Sands, Bruce E.
    Colombel, Jean-Frederic
    GASTROENTEROLOGY, 2008, 134 (04) : A492 - A492
  • [30] Long-term use of ozanimod in patients with moderately to severely active Ulcerative Colitis
    Danese, S.
    Colombel, J. F.
    Ponich, T.
    Jovanovic, I.
    Bossuyt, P.
    Longman, R.
    Alekseeva, O.
    Petersen, A.
    Chitkara, D.
    Marta, C.
    Charles, L.
    Rubin, D. T.
    Afzali, A.
    Loftus, E. V.
    Wolf, D. C.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I093 - I094
12345